Press "Enter" to skip to content

Novavax touts non-mRNA COVID-19 vaccine, hopeful to meet domestic production deadline

The last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.